A citation-based method for searching scientific literature

Christine S Walsh. Curr Opin Obstet Gynecol 2020
Times Cited: 12







List of co-cited articles
12 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
33

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
25

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.
Richard T Penson, Ricardo Villalobos Valencia, David Cibula, Nicoletta Colombo, Charles A Leath, Mariusz Bidziński, Jae-Weon Kim, Joo Hyun Nam, Radoslaw Madry, Carlos Hernández,[...]. J Clin Oncol 2020
45
16

Treatment of recurrent epithelial ovarian cancer.
Sandro Pignata, Carmela Pisano, Marilena Di Napoli, Sabrina Chiara Cecere, Rosa Tambaro, Laura Attademo. Cancer 2019
19
16

Advances in ovarian cancer therapy.
Alexander J Cortez, Patrycja Tudrej, Katarzyna A Kujawa, Katarzyna M Lisowska. Cancer Chemother Pharmacol 2018
183
16

Ovarian Cancer Immunotherapy: Turning up the Heat.
Eleonora Ghisoni, Martina Imbimbo, Stefan Zimmermann, Giorgio Valabrega. Int J Mol Sci 2019
57
16

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
16

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.
Ahmed Ashour Ahmed, Dariush Etemadmoghadam, Jillian Temple, Andy G Lynch, Mohamed Riad, Raghwa Sharma, Colin Stewart, Sian Fereday, Carlos Caldas, Anna Defazio,[...]. J Pathol 2010
439
16


The forefront of ovarian cancer therapy: update on PARP inhibitors.
M R Mirza, R L Coleman, A González-Martín, K N Moore, N Colombo, I Ray-Coquard, S Pignata. Ann Oncol 2020
43
16

Ovarian cancer.
Gordon C Jayson, Elise C Kohn, Henry C Kitchener, Jonathan A Ledermann. Lancet 2014
969
16

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.
Jing Yu, Wen Ouyang, Melvin L K Chua, Conghua Xie. JAMA Oncol 2020
572
8


PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells.
Boyun Kim, Je Won Jung, Jaeyoung Jung, Youngjin Han, Dong Hoon Suh, Hee Seung Kim, Danny N Dhanasekaran, Yong Sang Song. Oncotarget 2017
26
8

ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2-/- Ovarian Cancer Cells.
Lu Liu, Shurui Cai, Chunhua Han, Ananya Banerjee, Dayong Wu, Tiantian Cui, Guozhen Xie, Junran Zhang, Xiaoli Zhang, Eric McLaughlin,[...]. Mol Cancer Ther 2020
13
8



BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.
Britta Stordal, Kirsten Timms, Angela Farrelly, Danielle Gallagher, Steven Busschots, Mickaël Renaud, Julien Thery, Deborah Williams, Jennifer Potter, Thanh Tran,[...]. Mol Oncol 2013
90
8

Cancer stem cells revisited.
Eduard Batlle, Hans Clevers. Nat Med 2017
871
8

Rgnef promotes ovarian tumor progression and confers protection from oxidative stress.
Elizabeth G Kleinschmidt, Nichol L G Miller, Duygu Ozmadenci, Isabelle Tancioni, Carlos Díaz Osterman, Allison M Barrie, Kristin N Taylor, Aaron Ye, Shulin Jiang, Denise C Connolly,[...]. Oncogene 2019
9
11

ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer.
Arun Kanakkanthara, Catherine J Huntoon, Xiaonan Hou, Minzhi Zhang, Ethan P Heinzen, Daniel R O'Brien, Ann L Oberg, S John Weroha, Scott H Kaufmann, Larry M Karnitz. Nat Commun 2019
5
20


A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.
Nkechiyere G Nwani, Salvatore Condello, Yinu Wang, Wendy M Swetzig, Emma Barber, Thomas Hurley, Daniela Matei. Cancers (Basel) 2019
21
8

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, Barbara M Norquist, Elizabeth M Swisher, Mark F Brady, Michael A Bookman, Gini F Fleming, Helen Huang, Howard D Homesley,[...]. J Clin Oncol 2019
112
8

Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization.
Stephanie Lheureux, Zhongwu Lai, Brian A Dougherty, Sarah Runswick, Darren R Hodgson, Kirsten M Timms, Jerry S Lanchbury, Stan Kaye, Charlie Gourley, David Bowtell,[...]. Clin Cancer Res 2017
68
8

ALDH as a Stem Cell Marker in Solid Tumors.
Mariel E Toledo-Guzmán, Miguel Ibañez Hernández, Ángel A Gómez-Gallegos, Elizabeth Ortiz-Sánchez. Curr Stem Cell Res Ther 2019
39
8

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
Rebecca Borella, Luca Forti, Lara Gibellini, Anna De Gaetano, Sara De Biasi, Milena Nasi, Andrea Cossarizza, Marcello Pinti. Molecules 2019
18
8

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tomonori Tanei, Koji Morimoto, Kenzo Shimazu, Seung Jin Kim, Yoshio Tanji, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi. Clin Cancer Res 2009
406
8

Cancer stem cell metabolism: target for cancer therapy.
Young Chan Chae, Jae Ho Kim. BMB Rep 2018
49
8

Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells.
Sajad Dar, Jasdeep Chhina, Ismail Mert, Dhananjay Chitale, Thomas Buekers, Hareena Kaur, Shailendra Giri, Adnan Munkarah, Ramandeep Rattan. Sci Rep 2017
47
8

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.
Ayesha B Alvero, Rui Chen, Han-Hsuan Fu, Michele Montagna, Peter E Schwartz, Thomas Rutherford, Dan-Arin Silasi, Karina D Steffensen, Marianne Waldstrom, Irene Visintin,[...]. Cell Cycle 2009
340
8

Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells.
Francesca Rolle, Valeria Bincoletto, Elena Gazzano, Barbara Rolando, Giovanna Lollo, Barbara Stella, Chiara Riganti, Silvia Arpicco. Int J Pharm 2020
10
10

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Ines A Silva, Shoumei Bai, Karen McLean, Kun Yang, Kent Griffith, Dafydd Thomas, Christophe Ginestier, Carolyn Johnston, Angela Kueck, R Kevin Reynolds,[...]. Cancer Res 2011
344
8

The Molecular Signatures Database (MSigDB) hallmark gene set collection.
Arthur Liberzon, Chet Birger, Helga Thorvaldsdóttir, Mahmoud Ghandi, Jill P Mesirov, Pablo Tamayo. Cell Syst 2015
8

A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells.
Ilana Chefetz, Edward Grimley, Kun Yang, Linda Hong, Ekaterina V Vinogradova, Radu Suciu, Ilya Kovalenko, David Karnak, Cynthia A Morgan, Mikhail Chtcherbinine,[...]. Cell Rep 2019
43
8

CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.
Erhong Meng, Beverely Long, Paula Sullivan, Steve McClellan, Michael A Finan, Eddie Reed, Lalita Shevde, Rodney P Rocconi. Clin Exp Metastasis 2012
113
8

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.
Rachel M Hurley, Andrea E Wahner Hendrickson, Daniel W Visscher, Peter Ansell, Maria I Harrell, Jill M Wagner, Vivian Negron, Krista M Goergen, Matthew J Maurer, Ann L Oberg,[...]. Gynecol Oncol 2019
26
8


Elesclomol induces cancer cell apoptosis through oxidative stress.
Jessica R Kirshner, Suqin He, Vishwasenani Balasubramanyam, Jane Kepros, Chin-Yu Yang, Mei Zhang, Zhenjian Du, James Barsoum, John Bertin. Mol Cancer Ther 2008
139
8

Predicting the molecular complexity of sequencing libraries.
Timothy Daley, Andrew D Smith. Nat Methods 2013
128
8

Aldehyde dehydrogenase 1A1 expression in breast cancer is associated with stage, triple negativity, and outcome to neoadjuvant chemotherapy.
Thaer Khoury, Foluso O Ademuyiwa, Rameela Chandrasekhar, Marah Jabbour, Albert Deleo, Soldano Ferrone, Yangyang Wang, Xinhui Wang. Mod Pathol 2012
50
8

Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.
P Liu, S Brown, T Goktug, P Channathodiyil, V Kannappan, J-P Hugnot, P-O Guichet, X Bian, A L Armesilla, J L Darling,[...]. Br J Cancer 2012
176
8

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
8

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study.
Bradley J Monk, James T Kauderer, Katherine M Moxley, Albert J Bonebrake, Summer B Dewdney, Angeles Alvarez Secord, Frederick R Ueland, Carolyn M Johnston, Carol Aghajanian. Gynecol Oncol 2018
7
14

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.
Anna Pastò, Chiara Bellio, Giorgia Pilotto, Vincenzo Ciminale, Micol Silic-Benussi, Giulia Guzzo, Andrea Rasola, Chiara Frasson, Giorgia Nardo, Elisabetta Zulato,[...]. Oncotarget 2014
155
8

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
680
8

A brief review of the management of platinum-resistant-platinum-refractory ovarian cancer.
Bryan Oronsky, Carolyn M Ray, Alexander I Spira, Jane B Trepel, Corey A Carter, Hope M Cottrill. Med Oncol 2017
66
8

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Amit M Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes,[...]. Lancet Oncol 2015
364
8

Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?
Zahra Ghanbari Movahed, Mohsen Rastegari-Pouyani, Mohammad Hossein Mohammadi, Kamran Mansouri. Biomed Pharmacother 2019
42
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.